Lv2
150 积分 2022-05-21 加入
Brief report: Ivonescimab combined with etoposide plus carboplatin as first-line treatment for extensive-stage small-cell lung cancer: results of a phase Ib clinical trial
1天前
待确认
Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs
25天前
已完结
Cancer-targeting antibody–drug conjugates drive dealmaking frenzy
4个月前
已完结
Quantitative Membrane Proteomics for Discovery of Actionable Drug Targets at the Surface of RAS-Driven Human Cancer Cells
5个月前
已关闭
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
5个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
5个月前
已完结
A Gene‐Editable Palladium‐Based Bioorthogonal Nanoplatform Facilitates Macrophage Phagocytosis for Tumor Therapy
10个月前
已完结
CD6 triggers actomyosin cytoskeleton remodeling after binding to its receptor complex
1年前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
1年前
已完结
A timeline of tumour-associated macrophage biology
1年前
已完结
皖公网安备34019202002308
